Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMBO-PTA: Dexamethasone for Restenosis in CLI
NCT02479555Phase 2Unknown
- Sponsor
- Mercator MedSystems
- Start
- Jan 2016
- Primary completion
- Aug 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in critical limb ischemia (CLI), sponsored by Mercator MedSystems. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT02479555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479555.